Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosa damascena extract versus mefenamic acid for primary dysmenorrhea pain
IRCT201207267618N2Phase 3Completed
- Sponsor
- Research Deputy of Tabriz University of Medical Sciences
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Mefenamic acid in primary dysmenorrhea (PD) (2 arms), sponsored by Research Deputy of Tabriz University of Medical Sciences. Started Sep 2012; status: completed.
02
Drugs
Mefenamic acid
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on IRCT201207267618N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201207267618N2.